Your accommodation (up to 2 nights) will be covered by the conference. Travel costs will be covered for the first 100 registrants with a maximum for Europe €250,-, for the US €750,- and for Asia €850,-.
Audience Practicing physicians involved in the treatment of diabetes, as well as target/drug discovery scientists, pharmaceutical industry, drug registration regulators, clinical trialists, payers, patient organisations involved in drug development and clinical trials on progression of diabetes related complications.